BSI is the consultant for CE mark - Oncosil reported that must...

BSI is the consultant for CE mark - Oncosil reported that must have paid extra to use their fast track services a year or more ago - what they have been doing with Oncosil is unknown in terms of why this has all taken so long to come back finally with a rejection - I would be asking Oncosil of their opinion of BSI - and whether they should continue with their services seems not to have helped the position for any of us. Personally Oncosil should cut their losses with BSI and look for a new firm to represent them - using an Australian office to communicate with a backlog of devices in the EU may be part of the problem. Possibly they should choose a boutique firm based in Europe. While BSI has many offices it may be that you want a smaller group more focused solely based in Europe to push the agenda. I would also consider the regulatory documents and look at other areas to file such as the TGA or Singapore - at least they can generate regulatory data that could be used to support an EU re-submission. At least that would give the market some confidence. They could also try a fast track solution in Korea. There are many options to give some positive news to the market - being stubborn on Europe and hitting the share price does not do anyone any good. I am a long time hold but now I am frustrated. Possibly it is a time to buy back in if the price goes lower. There are many other examples where companies took a slide and bounced back but they need a new strategy.